144 related articles for article (PubMed ID: 35244929)
1. Epidemiological and anatomopathological profile of breast cancer in the region of North-West of Tunisia.
Mahjoub N; Ben Salem K; Mokrani A; Mansouri H; Achouri L; Chraiet N; Fehri R
Tunis Med; 2021 Avril; 99(4):441-448. PubMed ID: 35244929
[TBL] [Abstract][Full Text] [Related]
2. [Anatomopathological profile of breast cancer in cape bon, Tunisia].
Sahraoui G; Khanchel F; Chelbi E
Pan Afr Med J; 2017; 26():11. PubMed ID: 28450990
[TBL] [Abstract][Full Text] [Related]
3. Pathologically confirmed women's breast cancer: A descriptive study of Tunisian and Algerian series.
Sassi F; Rekaya MB; Belarbi A; Chilla D; Mansouri N; Achouri L; Saied E; Kassa R; Kacem LB; Ouezani M; Debabeche N; Rebhi F; Rammeh S
Cancer Rep (Hoboken); 2023 Sep; 6 Suppl 1(Suppl 1):e1818. PubMed ID: 37092543
[TBL] [Abstract][Full Text] [Related]
4. Outcomes of locally advanced breast cancer patients with ≥ 10 positive axillary lymph nodes.
Koca E; Kuzan TY; Dizdar O; Babacan T; Sahin I; Ararat E; Altundag K
Med Oncol; 2013; 30(3):615. PubMed ID: 23729267
[TBL] [Abstract][Full Text] [Related]
5. The prognostic significance of pathological features in Her-2 overexpressing breast carcinomas: A single institution experience in southern Tunisia.
Charfi S; Toumi N; Triki S; Kallel R; Kebaïli S; Chaabane K; Khabir A; Daoud J; Frikha M; Boudawara TS
Breast Dis; 2015; 35(4):233-9. PubMed ID: 26397770
[TBL] [Abstract][Full Text] [Related]
6. First report on molecular breast cancer subtypes and their clinico-pathological characteristics in Eastern Morocco: series of 2260 cases.
Elidrissi Errahhali M; Elidrissi Errahhali M; Ouarzane M; El Harroudi T; Afqir S; Bellaoui M
BMC Womens Health; 2017 Jan; 17(1):3. PubMed ID: 28068979
[TBL] [Abstract][Full Text] [Related]
7. [Clinicopathological characteristics and prognosis of different molecular types of breast cancer].
Liu ZF; Chen C; Yao XL; Sun SR
Zhonghua Yi Xue Za Zhi; 2016 Jun; 96(22):1733-7. PubMed ID: 27356638
[TBL] [Abstract][Full Text] [Related]
8. Correlation of HER-2 over-expression with clinico-pathological parameters in Tunisian breast carcinoma.
Ayadi L; Khabir A; Amouri H; Karray S; Dammak A; Guermazi M; Boudawara T
World J Surg Oncol; 2008 Oct; 6():112. PubMed ID: 18945339
[TBL] [Abstract][Full Text] [Related]
9. Descriptive analysis of molecular subtypes in Tunisian breast cancer.
Fourati A; Boussen H; El May MV; Goucha A; Dabbabi B; Gamoudi A; Sfar R; Rahal K; El May A; Ben Abdallah M
Asia Pac J Clin Oncol; 2014 Jun; 10(2):e69-74. PubMed ID: 23176549
[TBL] [Abstract][Full Text] [Related]
10. Prognostic factors in inflammatory breast cancer: A single-center study.
Kridis WB; Feki A; Khmiri S; Toumi N; Chaabene K; Daoud J; Ayedi I; Khanfir A
Breast Dis; 2022; 41(1):461-469. PubMed ID: 36641655
[TBL] [Abstract][Full Text] [Related]
11. Overview of resistance to systemic therapy in patients with breast cancer.
Gonzalez-Angulo AM; Morales-Vasquez F; Hortobagyi GN
Adv Exp Med Biol; 2007; 608():1-22. PubMed ID: 17993229
[TBL] [Abstract][Full Text] [Related]
12. Adjuvant endocrine therapy alone in patients with node-positive, luminal A type breast cancer.
Park S; Lee SK; Paik HJ; Ryu JM; Kim I; Bae SY; Yu J; Kim SW; Lee JE; Nam SJ
Medicine (Baltimore); 2017 Jun; 96(22):e6777. PubMed ID: 28562530
[TBL] [Abstract][Full Text] [Related]
13. Triple negative breast cancer: A clinico-epidemiological and histopronostic study of 90 cases.
Darouich S; El Amine El Hadj O; Betaieb I; Goucha A; Dhiab T; Rahal K; Gamoudi A; El May A
Tunis Med; 2017 Jan; 95(1):37-44. PubMed ID: 29327767
[TBL] [Abstract][Full Text] [Related]
14. Breast cancer in Tunisia: clinical and pathological findings.
Missaoui N; Jaidene L; Abdelkrim SB; Abdelkader AB; Beizig N; Yaacoub LB; Yaacoubi MT; Hmissa S
Asian Pac J Cancer Prev; 2011; 12(1):169-72. PubMed ID: 21517252
[TBL] [Abstract][Full Text] [Related]
15. Distribution of molecular breast cancer subtypes among Algerian women and correlation with clinical and tumor characteristics: a population-based study.
Cherbal F; Gaceb H; Mehemmai C; Saiah I; Bakour R; Rouis AO; Boualga K; Benbrahim W; Mahfouf H
Breast Dis; 2015; 35(2):95-102. PubMed ID: 25736840
[TBL] [Abstract][Full Text] [Related]
16. Better predictive value of axillary lymph node (ALN) status after systemic therapy for operable HER2-overexpressing breast cancer: A single-institution retrospective study.
Zhang Y; Mo M; Li JW; Zhou Y; Wu J; Yu KD; Shen ZZ; Shao ZM; Liu GY
Eur J Surg Oncol; 2016 Aug; 42(8):1146-52. PubMed ID: 27365197
[TBL] [Abstract][Full Text] [Related]
17. Can we identify the group of small invasive (T1a,b) breast cancers with minimal risk of axillary lymph node involvement? A pathohistological and DNA flow cytometric study.
Bezić J; Samija-Projić I; Projić P; Ljubković J; Capkun V; Tomić S
Pathol Res Pract; 2011 Jul; 207(7):438-42. PubMed ID: 21689895
[TBL] [Abstract][Full Text] [Related]
18. Triple negative breast cancer in Moroccan women: clinicopathological and therapeutic study at the National Institute of Oncology.
Rais G; Raissouni S; Aitelhaj M; Rais F; Naciri S; Khoyaali S; Abahssain H; Bensouda Y; Khannoussi B; Mrabti H; Errihani H
BMC Womens Health; 2012 Oct; 12():35. PubMed ID: 23039971
[TBL] [Abstract][Full Text] [Related]
19. [Lobular invasive breast cancer prognostic factors: About 940 patients].
Jauffret C; Houvenaeghel G; Classe JM; Garbay JR; Giard S; Charitansky H; Cohen M; Bélichard C; Faure C; Darai É; Hudry D; Azuar P; Villet R; Gimbergues P; Tunon de Lara C; Martino M; Coutant C; Dravet F; Chauvet MP; Chéreau Ewald E; Penault-Llorca F; Goncalves A; Lambaudie É
Gynecol Obstet Fertil; 2015 Nov; 43(11):712-7. PubMed ID: 26482833
[TBL] [Abstract][Full Text] [Related]
20. Immunohistochemical profile of breast cancer patients at a tertiary care hospital in South India.
Ambroise M; Ghosh M; Mallikarjuna VS; Kurian A
Asian Pac J Cancer Prev; 2011; 12(3):625-9. PubMed ID: 21627355
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
